Market Overview

The Global Glaucoma Treatment Market was valued at USD 6,177.2 million in 2023 and is expected to reach USD 8,717.6 million by 2031 while growing at a CAGR of 4.4% during the forecast period (2024-2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Market Dynamics

This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global glaucoma treatment market growth. Glaucoma treatment focuses on managing the condition and halting additional vision loss by reducing intraocular pressure (IOP), the main risk factor for optic nerve damage associated with glaucoma.

Ongoing research and development efforts result in the discovery of new drugs, devices, and surgical Disease Types for glaucoma treatment, while advances in drug delivery systems, imaging technologies, and surgical devices drive the glaucoma treatment market forward. Nonetheless, challenges such as high treatment costs and healthcare infrastructure limitations impede the growth of the market.

Furthermore, the global glaucoma treatment industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.

Segmentation – By Disease Type Analysis

The Global Glaucoma Treatment Market is segmented among Open Angle Glaucoma, Angle Closure Glaucoma, and Others, based on Disease Type. In 2023, Open Angle Glaucoma accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Segmentation – By Drug Class Analysis

The Global Glaucoma Treatment Market is segmented among Prostaglandin Analogs, Beta Blockers, Adrenergic Agonists, Carbonic Anhydrase Inhibitors, and Others, based on Drug Class. In 2023, Prostaglandin Analogs accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Global Glaucoma Treatment Market: Regional Analysis

Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Competitive Landscape

Some of the key players operating in the market are Novartis, Allergan, Pfizer, Akorn, Teva Pharmaceutical Industries, Bausch & Lomb, Santen Pharmaceutical Co., Lunan Pharma Group Holdings Ltd., Zizhu Pharmaceutical Co., Iridex, Glaukos Corporation, Transcend Therapeutics, Aerie Pharmaceuticals, Ivantis, Ocular Therapeutix, Regenxbio Inc., DORC Technologies SAS, Merck & Co., Johnson & Johnson Vision, and Roche Diagnostics International Ltd.

Table of Contents:

1. Research Methodology and Market Scope

• Research Methodology

• Market Scope

2. Executive Summary

3. Global Glaucoma Treatment Market Dynamics

• Drivers

• Restraints

• Opportunity

4. Global Glaucoma Treatment Industry Analysis

• PEST Analysis

• Porter's Five Force Analysis

• Recent Deals Analysis

5. Global Glaucoma Treatment Market Segmentation, By Disease Type

• Global Glaucoma Treatment Market Share Analysis, By Disease Type

• Global Glaucoma Treatment Market Growth Analysis, By Disease Type

• Global Glaucoma Treatment Market Trends, By Disease Type

o Open Angle Glaucoma

o Angle Closure Glaucoma

o Others

6. Global Glaucoma Treatment Market Segmentation, By Drug Class

• Global Glaucoma Treatment Market Share Analysis, By Drug Class

• Global Glaucoma Treatment Market Growth Analysis, By Drug Class

• Global Glaucoma Treatment Market Trends, By Drug Class

o Prostaglandin Analogs

o Beta Blockers

o Adrenergic Agonists

o Carbonic Anhydrase Inhibitors

o Others

7. Global Glaucoma Treatment Market Segmentation, By Distribution Channel

• Global Glaucoma Treatment Market Share Analysis, By Distribution Channel

• Global Glaucoma Treatment Market Growth Analysis, By Distribution Channel

• Global Glaucoma Treatment Market Trends, By Distribution Channel

o Hospital Pharmacy

o Retail Pharmacy

o Online Pharmacy    

8. Global Glaucoma Treatment Market Segmentation, By Region

• Global Glaucoma Treatment Market Share Analysis, By Region

• Global Glaucoma Treatment Market Growth Analysis, By Region

• Global Glaucoma Treatment Market Trends, By Region

o North America

o Europe

o Asia Pacific

o Latin America

o Middle East

o Africa

9. Competitive Landscape

• Novartis*

o Company Overview

o Financial Performance

o Key Development/Strategies

o SWOT Analysis

• Allergan

• Pfizer

• Akorn

• Teva Pharmaceutical Industries

• Bausch & Lomb

• Santen Pharmaceutical Co.

• Lunan Pharma Group Holdings Ltd.

• Zizhu Pharmaceutical Co.

• Iridex

• Glaukos Corporation

• Transcend Therapeutics

• Aerie Pharmaceuticals

• Ivantis

• Ocular Therapeutix

• Regenxbio Inc.

• DORC Technologies SAS

• Merck & Co.

• Johnson & Johnson Vision

• Roche Diagnostics International Ltd.

*Similar analysis will be provided for each company listed above.